Neumora Therapeutics, Common Stock Price on September 26, 2024
| NMRA Stock | 9.80 0.14 1.41% |
If you're considering investing in Neumora Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neumora Therapeutics, stands at 9.80, as last reported on the 4th of December, with the highest price reaching 10.02 and the lowest price hitting 9.63 during the day. Neumora Therapeutics, has Sharpe Ratio of -0.0084, which conveys that the firm had a -0.0084% return per unit of risk over the last 3 months. Neumora Therapeutics, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neumora Therapeutics,'s Standard Deviation of 4.69, risk adjusted performance of (0.01), and Mean Deviation of 3.37 to check out the risk estimate we provide.
At present, Neumora Therapeutics,'s Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 168.7 M, whereas Capital Stock is forecasted to decline to about 13 K. . At present, Neumora Therapeutics,'s Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 6.06, whereas Price Earnings Ratio is forecasted to decline to (12.05). Neumora Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neumora |
Sharpe Ratio = -0.0084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NMRA |
Estimated Market Risk
| 4.71 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neumora Therapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neumora Therapeutics, by adding Neumora Therapeutics, to a well-diversified portfolio.
Price Book 4.9364 | Book Value 2.384 | Enterprise Value 1.2 B | Enterprise Value Ebitda (4.65) | Shares Float 83.4 M |
Neumora Therapeutics, Main Headline on 26th of September 2024
Disposition of 136210 shares by Aurora Daljit Singh of Neumo... by Aurora Daljit Singh
Filed transaction by Neumora Therapeutics, Common Officer Chief Strategy Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Neumora Therapeutics, Valuation on September 26, 2024
It is possible to determine the worth of Neumora Therapeutics, on a given historical date. On September 26, 2024 Neumora was worth 12.99 at the beginning of the trading date compared to the closed value of 13.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neumora Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Neumora Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neumora Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neumora Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 12.32 | 12.94 | 12.00 | 12.80 | 894,838 | |
09/26/2024 | 12.99 | 13.27 | 12.52 | 13.08 | 536,759 |
| 13.19 | 13.44 | 12.77 | 12.92 | 801,514 |
| Backtest Neumora Therapeutics, | | | Neumora Therapeutics, History | | | Neumora Therapeutics, Valuation | Previous | Next |
Neumora Therapeutics, Trading Date Momentum on September 26, 2024
| On September 27 2024 Neumora Therapeutics, Common was traded for 12.92 at the closing time. The top price for the day was 13.44 and the lowest listed price was 12.77 . The trading volume for the day was 801.5 K. The trading history from September 27, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.22% . The trading delta at closing time against the current closing price is 12.54% . |
Neumora Therapeutics, Fundamentals Correlations and Trends
By evaluating Neumora Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neumora Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neumora financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neumora Therapeutics, Stock history
Neumora Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neumora is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neumora Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neumora Therapeutics, stock prices may prove useful in developing a viable investing in Neumora Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 158.8 M | 168.7 M | |
| Net Loss | -117.8 M | -123.7 M |
Neumora Therapeutics, Quarterly Net Working Capital |
|
Neumora Therapeutics, Stock Technical Analysis
Neumora Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neumora Therapeutics, Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Neumora Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neumora Therapeutics, December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Neumora Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neumora Therapeutics, shares will generate the highest return on investment. By undertsting and applying Neumora Therapeutics, stock market strength indicators, traders can identify Neumora Therapeutics, Common entry and exit signals to maximize returns
Neumora Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neumora Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Neumora Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neumora to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Neumora Stock analysis
When running Neumora Therapeutics,'s price analysis, check to measure Neumora Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neumora Therapeutics, is operating at the current time. Most of Neumora Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Neumora Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neumora Therapeutics,'s price. Additionally, you may evaluate how the addition of Neumora Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |